Is OCUL or OGEN more undervalued in 2026?

CirclFi compares Ocular Therapeutix, Inc. (OCUL) and Oragenics Inc. (OGEN) using 13 institutional-grade valuation models. OCUL has a Quality of Company score of 7.2/10 while OGEN scores 4.5/10.

Which is a better buy — OCUL or OGEN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do OCUL and OGEN valuations compare?

OCUL at $9.15 and OGEN at $0.60 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

OCUL vs OGEN Valuation Comparison 2026 — Intrinsic Value Analysis

OCUL

Biotechnology

Ocular Therapeutix, Inc.

Quality

7.2

out of 10

Value Trap

SAFE

Price

$9.15

Last close

Models

11/13

Active

OGEN

Biotechnology

Oragenics Inc.

Quality

4.5

out of 10

Value Trap

SAFE

Price

$0.60

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	OCUL Fair Value	OCUL Upside	OGEN Fair Value	OGEN Upside
Bayesian DCF	Intrinsic	$4.28	-53.2%	$0.90	+49.9%
Earnings Power Value	Intrinsic	$2.78	-70.6%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.11	-98.8%	$0.14	-76.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for OCUL vs OGEN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

OCUL vs OGEN — Which Stock Is More Undervalued?

OCUL scores higher with a 7.2/10 quality rating vs OGEN's 4.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Ocular Therapeutix, Inc. (OCUL) and Oragenics Inc. (OGEN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

OCUL currently trades at $9.15 with a QOC of 7.2/10, while OGEN trades at $0.60 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).